These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8491970)

  • 1. Medical treatment of ascites in cirrhosis.
    Gerbes AL
    J Hepatol; 1993; 17 Suppl 2():S4-9. PubMed ID: 8491970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of ascites associated with cirrhosis.
    Ginès P; Arrovo V; Rodés J
    Drugs; 1992 Mar; 43(3):316-32. PubMed ID: 1374317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loop diuretic therapy in liver cirrhosis with ascites.
    Laffi G; La Villa G; Carloni V; Foschi M; Bartoletti L; Quartini M; Gentilini P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S51-8. PubMed ID: 7506337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
    Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
    Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torasemide in the treatment of patients with cirrhosis and ascites.
    Gentilini P; Laffi G; La Villa G; Carloni V; Foschi M; Romanelli RG; Marra F
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():81-5. PubMed ID: 8435382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.
    Chang SC; Chang HI; Chen FJ; Shiao GM; Wang SS; Lee SD
    J Hepatol; 1997 Apr; 26(4):833-8. PubMed ID: 9126796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cirrhotic ascites.
    Alaniz C
    Clin Pharm; 1989 Sep; 8(9):645-54. PubMed ID: 2676316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
    Santos J; Planas R; Pardo A; Durández R; Cabré E; Morillas RM; Granada ML; Jiménez JA; Quintero E; Gassull MA
    J Hepatol; 2003 Aug; 39(2):187-92. PubMed ID: 12873814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
    Marelli A; Bodini P; Reggiani A; Quinzani M; Dizioli P; Tonghini L
    Minerva Med; 1997 Mar; 88(3):109-15. PubMed ID: 9148226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.